InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Fruchtman Steven M, Chief Executive Officer. Officer active across 1 company, notably Onconova Therapeutics, Inc.. Aggregated, 7 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €17k. Activity tracked since 28 September 2021. The latest transaction was disclosed on 28 September 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
23,111 sharesCommon StockSEC:0001415889-24-008141:0
21,320 sharesCommon StockSEC:0001415889-24-003204:0
12,567 sharesCommon StockSEC:0001415889-23-011866:0
21,320 sharesCommon StockSEC:0001415889-23-002171:0
12,566 sharesCommon StockSEC:0001415889-22-008258:0
▲
2,381 shares@ US$4.2050.0% of flowCommon StockSEC:0001179110-21-008956:0
Ideal exit: 25 Jun 2022 (T+270)
▲
2,381 shares@ US$4.2050.0% of flowCommon StockSEC:0001179110-21-008956
Ideal exit: 25 Jun 2022 (T+270)
7 of 7 declarations
About Fruchtman Steven M
Steven M Fruchtman is the President and Chief Executive Officer of Onconova Therapeutics, Inc. He is responsible for the strategic direction of the company, overseeing operations and development initiatives. His expertise in the biopharmaceutical sector is essential for guiding the company's growth and innovation.
